Rafael G Amado

Title: Rafael G Amado: Innovator in Gene Therapy

Introduction

Rafael G Amado is a prominent inventor based in Encino, California. He has made significant contributions to the field of gene therapy, particularly in the area of hematopoietic progenitor cells. With a total of three patents to his name, Amado's work focuses on innovative methods for treating and preventing diseases such as HIV.

Latest Patents

Amado's latest patents include a process for the preparation of a composition of genetically modified hematopoietic progenitor cells. This invention describes compositions and methods related to gene therapy, specifically for hematopoietic progenitor cells. The methods aim to provide prolonged engraftment of modified hematopoietic cells in human subjects. Another notable patent involves methods for genetic modification of hematopoietic progenitor cells, emphasizing ex vivo gene therapy for the treatment or prevention of HIV infection.

Career Highlights

Rafael G Amado is currently associated with Johnson & Johnson Research Pty Limited, where he continues to advance his research in gene therapy. His work has garnered attention for its potential impact on medical treatments and patient outcomes.

Collaborations

Amado has collaborated with notable colleagues in his field, including Geoffrey Phillip Symonds and Lun-Quan Sun. These partnerships have contributed to the development and refinement of his innovative approaches to gene therapy.

Conclusion

Rafael G Amado stands out as a key figure in the realm of gene therapy, with a focus on hematopoietic progenitor cells. His patents reflect a commitment to advancing medical science and improving treatment options for patients.